Education
About Us
Working with TipRanks
Follow Us
Sanara MedTech (SMTI)
:SMTI
Total Valuation
Sanara MedTech has a market cap or net worth of $284.33M. The enterprise value is $299.16M.
Market Cap$284.33M
Enterprise Value$299.16M
Share Statistics
Sanara MedTech has 8,887,984 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,887,984
Owned by Insiders51.54%
Owned by Institutions0.25%
Financial Efficiency
Sanara MedTech’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -9.13%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-9.13%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee614.70K
Profits Per Employee-70.30K
Employee Count141
Asset Turnover0.98
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Sanara MedTech is -29.15. Sanara MedTech’s PEG ratio is -0.24.
PE Ratio-29.15
PS Ratio3.76
PB Ratio7.15
Price to Fair Value7.15
Price to FCF-1.23K
Price to Operating Cash Flow-11.84K
PEG Ratio-0.24
Income Statement
In the last 12 months, Sanara MedTech had revenue of 86.67M and earned -9.66M in profits. Earnings per share was -1.14.
Revenue86.67M
Gross Profit78.53M
Operating Income-6.72M
Pretax Income-9.66M
Net Income-9.66M
EBITDA-1.86M
Earnings Per Share (EPS)-1.14
Cash Flow
In the last 12 months, operating cash flow was -23.78K and capital expenditures -229.30K, giving a free cash flow of -253.08K billion.
Operating Cash Flow-23.78K
Free Cash Flow-253.08K
Free Cash Flow per Share-0.03
Dividends & Yields
Sanara MedTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change-1.95%
50-Day Moving Average31.86
200-Day Moving Average32.84
Relative Strength Index (RSI)55.33
Average Volume (3m)30.62K
Important Dates
Sanara MedTech upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateMar 25, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Sanara MedTech as a current ratio of 2.18, with Debt / Equity ratio of 4.05%
Current Ratio2.18
Quick Ratio2.00
Debt to Market Cap<0.01
Net Debt to EBITDA7.68
Interest Coverage Ratio-2.15
Taxes
In the past 12 months, Sanara MedTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sanara MedTech EV to EBITDA ratio is -143.74, with an EV/FCF ratio of -1.16K.
EV to Sales3.09
EV to EBITDA-143.74
EV to Free Cash Flow-1.16K
EV to Operating Cash Flow-11.24K
Balance Sheet
Sanara MedTech has $15.88M in cash and marketable securities with $1.60M in debt, giving a net cash position of -$14.28M billion.
Cash & Marketable Securities$15.88M
Total Debt$1.60M
Net Cash-$14.28M
Net Cash Per Share-$1.61
Tangible Book Value Per Share-$0.67
Margins
Gross margin is 89.33%, with operating margin of -7.75%, and net profit margin of -11.15%.
Gross Margin89.33%
Operating Margin-7.75%
Pretax Margin-11.15%
Net Profit Margin-11.15%
EBITDA Margin-2.15%
EBIT Margin-7.83%
Analyst Forecast
The average price target for Sanara MedTech is $48.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$48.50
Price Target Upside51.61% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast33.36%
EPS Growth Forecast-118.51%